Frequency of overexpression of Her2/neu in colorectal adenocarcinomas– A hospital based cross-sectional study

Original Article

Author Details : Neha Ratan B*, Vijayalaxmi V Suranagi

Volume : 7, Issue : 1, Year : 2020

Article Page : 24-32

Suggest article by email


Introduction: Colorectal malignancies stand out to be one of the chief causes of morbidity and mortality
in the world. Although the total incidence of colorectal malignancy in India n population has marginally
increased, it is now a common cause of cancer mortality among Indians.
The oncogene HER2/neu belongs to the tyrosine kinase receptor family. The favorable outcome of
HER2/neu in management of breast carcinoma patients has direct ed to evaluation of gene amplification
protein overexpression, and anti-tumor activity of Herceptin in various tumor types one amongst which
is colorectal carcinomas. The objective of the study was to evaluate the frequency of overexpression of
HER2/neu in colorectal adenocarcinomas (CRC) and its association with various histomorphological and
clinicopathological parameters.
Materials and Methods: A total of 52 cases of colorectal adenocarcinomas including colonoscopic
biopsies & resected specimens were studied. Paraffin embedded sections were stained with Hematoxylin &
Eosin and histological and clinicopathological parameters were assessed. In IHC, antigens were retrieved
by Heat Induced Epitope Retrieval method and HER2/ neu status was determined using a semiquantitative
scoring system. The scores were then correlated with histological grade, type and clinicopathological
Results: The HER2/neu overexpression was noted in 53.8% of our cases and was seen to be commonly
expressed by moderately differentiated tumours and conventional/ NOS histological type.
There was a statistically significant correlation observed between HER2/neu status and tumour grade (p=
0.001), tumour type (p = 0.008). There was no significant correlation between age, gender or localisation
or stage of tumour.
Conclusion: Histological grade and histological type of CRC showed a significant correlation with
HER2/neu overexpression, hence can be used as a predictive tool for determining the prognosis of the
Patients who overexpress HER2/neu could become potential candidates for this monoclonal antibody based
targeted immunotherapy thus reduce overall mortality and morbidity of CRC worldwide.

Keywords: HER2/neu, Colorectal adenocarcinoma.

How to cite : Neha Ratan B, Suranagi V V, Frequency of overexpression of Her2/neu in colorectal adenocarcinomas– A hospital based cross-sectional study. Indian J Pathol Oncol 2020;7(1):24-32

Copyright © 2020 by author(s) and Indian J Pathol Oncol. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (

View Article

PDF File   Full Text Article

Copyright permission

Get article permission for commercial use


PDF File   XML File   ePub File

Digital Object Identifier (DOI)

Article DOI


Article Metrics

Article Access statistics

Viewed: 342

PDF Downloaded: 241